{
  "subset": "indication",
  "disease": "Epileptic encephalopathy",
  "relation": "indication",
  "gold_drugs": [
    "anti-seizure medication",
    "matching placebo",
    "tak-935",
    "zx008"
  ],
  "seeds_initial": [
    "Stiripentol",
    "Rufinamide",
    "Clobazam",
    "Lacosamide",
    "Vigabatrin",
    "Perampanel",
    "Ezogabine",
    "Topiramate",
    "Lamotrigine",
    "Levetiracetam",
    "Carbamazepine",
    "Phenobarbital"
  ],
  "seed_history": [
    [
      "Stiripentol",
      "Rufinamide",
      "Clobazam",
      "Lacosamide",
      "Vigabatrin",
      "Perampanel",
      "Ezogabine",
      "Topiramate",
      "Lamotrigine",
      "Levetiracetam",
      "Carbamazepine",
      "Phenobarbital"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_stiripentol",
          "name": "Stiripentol"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H1_round5",
        "key_assumptions": [
          "已知支持对癫痫性脑病的治疗",
          "潜在的不良表型风险已被识别"
        ],
        "caveats": [
          "不良表型风险可能影响净收益"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_rufinamide",
          "name": "Rufinamide"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H2_round5",
        "key_assumptions": [
          "已知支持对癫痫性脑病的治疗",
          "潜在的不良表型风险已被识别"
        ],
        "caveats": [
          "不良表型风险可能影响净收益"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_clobazam",
          "name": "Clobazam"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H3_round5",
        "key_assumptions": [
          "已知支持对癫痫性脑病的治疗",
          "潜在的不良表型风险已被识别"
        ],
        "caveats": [
          "不良表型风险可能影响净收益"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Disease",
          "reason": "支持药物治疗癫痫性脑病的证据充分"
        }
      ],
      "remaining_gaps": [
        "需要进一步的研究来明确不良表型影响及其机制"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that could be indicated for the rare disease 'Epileptic encephalopathy'. Return only names.\n\n# Heuristics:\n- When 药物对癫痫表型的潜在影响: then 考察长期疗效与风险关系，确保临床数据支持"
}